Although there is no cure for narcolepsy, medication and lifestyle changes can help manage the symptoms. Medicines that ...

Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

A group of Edmonton parents of children with disabilities says their Charter rights to education are being violated because of a decision made by Alberta's education minister.

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

Royal Bank of Canada reaffirmed their outperform rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a report published on Wednesday morning,Benzinga reports. They currently have a ...

Picking up our series on potential medical issues found in famous works of art, Dr Keith Hopcroft considers this famous ...

The Driver and Vehicle Licensing Agency (DVLA) is warning drivers about various medical conditions that could affect their ability to drive. It urges individuals to declare any listed conditions to ...

While we know that babies born in January are more likely to be famous and become doctors, what about February babies?

Cantor Fitzgerald upgraded shares of Zevra Therapeutics (NASDAQ:ZVRA – Free Report) to a strong-buy rating in a research note issued to investors on Wednesday,Zacks.com reports. Other equities ...

However, if you have a medical condition that affects your driving but don't voluntarily give up your licence, you must inform the DVLA, which will decide if you can continue holding a driving licence ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will ...